Immunodiagnostics Market By Type (Immunodiagnostic Instruments, Immunoassays), By Application (Oncology and Endocrinology, Hepatitis and Retrovirus Testing, Infectious Disease Testing, GI Stool Testing), Technology(Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test and Others) and By Region- Trends, Analysis and Forecast till 2029

Immunodiagnostics Market accounted for USD 19.30 Billion in 2020 and is estimated to be USD 39.69 Billion by 2030 and is anticipated to register a CAGR of 7.50%.

Immunodiagnostics is a diagnostic procedure that relies heavily on the antigen-antibody response as a key mechanism of detection. Antibodies that are specific for a particular antigen can be coupled with a radiolabel, fluorescent label, or color-forming enzyme and used as a probe to detect it. Because of the speed, accuracy, and simplicity of such testing, quick procedures for diagnosing disease, microorganisms, and even illegal narcotics in vivo have been developed.

Increased prevalence of infectious diseases

The increased prevalence of infectious diseases, cardiovascular diseases, cancer, gastrointestinal diseases, and other chronic diseases, as well as changes in demography and lifestyle, are likely to drive the growth of the immunodiagnostics market over the forecast period. Furthermore, technological advancements in diagnosis kits, assays, and analyzers, as well as an increase in awareness of preventative health measures among patients and medical professionals, are a few of the factors expected to drive the growth of the immunodiagnostics market. The rigorous governing circumstances, on the other hand, are one of the reasons that are expected to restrict the expansion of the immunodiagnostics market in the near future.

Furthermore, technical advancements in diagnosis kits, assays, and analyzers, as well as increased awareness of preventive health measures among patients and medical professionals, generate demand for immunodiagnostics goods, driving growth. However, a number of obstacles are predicted to hinder market growth. The impact of the drivers is projected to be greater than the impact of the constraints. Furthermore, an increase in the impact of the drivers and restraints is expected to open up new market opportunities for key companies manufacturing immunodiagnostics products, particularly kits and assays.

Immunodiagnostics Market report segments the market on the basis of type, technology, application and region.

On the basis of Type, the Global Immunodiagnostics Market is segmented into Immunodiagnostic Instruments, Immunoassays. Based on Technology the market is segmented into Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test and Others. Based on Application the market is segmented into Oncology and Endocrinology, Hepatitis and Retrovirus Testing, Infectious Disease Testing, GI Stool Testing.

Regional Insights:

On region the Immunodiagnostics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the immunodiagnostics market due to increase in the need for immunodiagnostics tests, an increase in the older population, and an increase in the occurrences of chronic and infectious diseases. Furthermore, an increase in customer awareness of early disease management will encourage them to undergo frequent tests and check-ups, boosting the growth of the immunodiagnostics market in the area during the projection period. Because of increased investments by several major players, a rise in awareness, advancements in health care infrastructure, and appropriate legislative changes, Asia Pacific is expected to witness considerable growth in the immunodiagnostics market.

Immunodiagnostics Market Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Immunodiagnostics Market report based on Type, Technology, Application and Region.

Immunodiagnostics Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating in the Immunodiagnostics Market includes Abbott Laboratories, Immunodiagnostic Systems Holdings Plc (IDS), DiaSorin S.p.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Siemens AG, Sysmex Corporation, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and Arkray, Inc.

• Thermo Fisher Scientific bought Mesa Biotech (US) in February 2021 to enhance the benefits of molecular diagnostics at the point of care.
• Abbott Laboratories will introduce the ID NOW COVID-19 Test in March 2020.

• Abbott Laboratories
• Immunodiagnostic Systems Holdings Plc (IDS)
• DiaSorin S.p.A.
• Johnson & Johnson
• F. Hoffmann-La Roche Ltd
• Siemens AG
• Sysmex Corporation
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.